Where is the product shipped from?

The nearest ports for shipment are Guangzhou Port and Shenzhen Port.

Feline Leukemia Virus Antigen Rapid Test

Name: Feline Leukemia Virus Antigen Rapid Test
Brand: Guangzhou Herun Bio-Pharm Co., Ltd.
SKU: 2083534272

Guangdong, ChinaGuangzhou Herun Bio-Pharm Co., Ltd.

US$1.00-2.00

100 Pieces

Product profile

Customization

Available

Type

Detection Card

Syringe

Test Kit

Model NO.

HA-39

Blood Sampling Needle

Test Kit

Breathing Pattern

Test Kit

Animal Anesthesia Machine Control Method

Test Kit

Package

10t/20t/Box

Warranty

12 Months

Animals

Cat

Transport Package

Carton

Specification

1PC/Aluminum Foil Bag, 20PCS/Box.

Trademark

CHEMICOS

Origin

Guangzhou, China

HS Code

38220090

Production Capacity

100000 Pieces/Day

Key features

12 Months Warranty: Comprehensive warranty coverage for 12 months to ensure product reliability and customer peace of mind.

OEM/ODM Support: Full OEM and ODM services available to meet specific branding and manufacturing requirements.

Easy Result Interpretation: Clear and precise results allow for quick decision-making with confidence in accuracy.

Flexible Packaging: Customizable packaging options available in 10 or 20 units per box.

Low MOQ: Minimum Order Quantity is just 1 piece, ideal for small-scale testing or sampling.

Company profile

Exhibition ExperienceLow MOQCustomization from SamplesODM Services

Guangzhou Herun Bio-Pharm Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedExport Year: N/A CertifiedNearest Port: Guangzhou Port, Shenzhen PortAverage Response Time: ≤9.90h CertifiedTerms of Payment: T/T

AI-Powered supplier vetting

SummaryThe supplier operates across services, forestry, animal husbandry and fishery, medical research, and sales of specialized medical, optical, agricultural, and testing equipment. It provides 3D design, ODM, OEM, SDK, and multiple customization services. Documented procedures exist for supplier assessment, corrective and preventive actions, and complaint handling, but quality assurance and raw-material traceability statuses are unknown. The supplier reports no new products in the past year and no inventory, overseas warehouse, or overseas showroom capability. Financial records are indicated for 2021–2023, but the provided data does not disclose performance results. Its company description emphasizes diagnostic products, protein-expression technology, R&D investment, and collaboration with universities and institutions.

Supplier typeThe supplier is a diversified service and technology-oriented company covering agricultural, forestry, animal husbandry and fishery, medical research, and specialized instrument and medical-device sales. Its stated focus on diagnostic products and solutions for human and animal health further indicates a life-science and healthcare-related supplier profile.

After-Sales capabilityThe supplier has a clear, documented complaint-handling procedure with implementation records and documented service-capability assessment procedures. However, no specific response scope, service network, or after-sales performance information is provided.

R&D capabilityThe supplier provides ODM services, OEM services for well-known brands, an available SDK, 3D design, and multiple design-customization options. Its description also cites product-development technology platforms, R&D investment, experienced scientists, and university or institutional collaboration; however, it launched no new products during the past year.

Customization capabilityThe supplier explicitly supports customization from samples, customization from designs, and full customization, along with 3D software design and ODM services. These statements provide direct evidence of broad product and design customization capability.